QZ6-15752-08155
4 vaccinations
2 coded responses
44 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 930 / CA
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 1 — Moderna
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-29
- 2021-02-05
-
2021-02-12
Dose 2 — Moderna
- 2021-02-12
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-05-14
- 2021-08-13
-
2021-10-29
Dose 3 — Moderna
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
-
2022-01-28
Survey response — 3 months, dose 3MedDRA: Gestational diabetes, Pre-eclampsia, Pregnancy — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · HospitalizationFree text: Pregnant, gestational diabetes, preeclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-01-28
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
-
2022-01-31
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-04-29
-
2022-09-12
Dose 4 — Moderna
- 2022-09-30
- 2022-10-05
- 2022-10-10
-
2022-10-24
Survey response — day 42, dose 4MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-12-12
- 2023-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Moderna | |
| 2 | 2021-02-12 | Moderna | |
| 3 | 2021-10-29 | Moderna | No |
| 4 | 2022-09-12 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 3 months, dose 3
Symptoms: Pregnant, gestational diabetes, preeclampsia
Release 12 — day 42, dose 4
Symptoms: Sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gestational diabetes | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release